LPC
ELVN icon

Lion Point Capital’s Enliven Therapeutics ELVN Stock Holding History

Lion Point Capital’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-208,695
Closed -$1.14M – 42
2022
Q2 		$1.14M Hold
208,695
– – 0.13% 36
2022
Q1 		$1.57M Buy
+208,695
New +$1.38M 0.36% 27
2021
Q4 		– Sell
-208,333
Closed -$3.4M – 35
2021
Q3 		$3.4M Buy
+208,333
New +$4.33M 0.64% 25

Other funds holding ELVN

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return